MVP medical developments international limited

Ann: Penthrox approved in Germany, page-4

  1. 2,018 Posts.
    lightbulb Created with Sketch.  31
    Nice
    Another 80 million customers
    With the opiod statement, this bodes well for USA.
    Prost!


    Penthrox approved in Germany

    Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Germany. MVP CEO, Mr. John Sharman said, “We are excited that the Marketing Authorisation for Germany has been received. Germany is one of the most important markets for MVP, as the country is seen by many as a leader in pain drugs and therefore their imprimatur is doubly important for us.

    Mr Sharman said: “With a population of almost 83 million people Germany is the largest spender on healthcare in Europe. Germany is also the largest user of opioids in Europe. We anticipate millions of patients could benefit from the introduction of Penthrox as a non-opioid, rapid and safe pain relief treatment.”
    Last edited by blueskymine01: 05/04/18
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
46.0¢
Change
0.020(4.55%)
Mkt cap ! $49.56M
Open High Low Volume
45.0¢ 46.0¢ 45.0¢ 53.96K

Buyers (Bids)

Vol. Price($)
22000 44.5¢
 

Sellers (Offers)

Price($) Vol.
47.5¢ 2300
Last trade - 16.26pm 31/07/2026 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.